Investor Overview

NASDAQ: XBIT0.364.52Data provided by Nasdaq.
Minimum 15 minutes delayed.

XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

Recent News
DateTitle 
12/04/17XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative DermatologyPrinter Friendly Version
11/14/17XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific SessionsPrinter Friendly Version
11/03/17XBiotech’s MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific SessionsPrinter Friendly Version

Read more »

Upcoming Events

There are currently no events scheduled.

Read more »